Haroon Afzal , Nguyen-Thanh Hoa , Asad Murtaza , Thu-Dung Doan , Yao-Chi Chung , Guan-Ming Ke , Li-Ting Cheng
{"title":"猪流行性腹泻病毒灭活疫苗中鞭毛蛋白保守结构域的佐剂作用。","authors":"Haroon Afzal , Nguyen-Thanh Hoa , Asad Murtaza , Thu-Dung Doan , Yao-Chi Chung , Guan-Ming Ke , Li-Ting Cheng","doi":"10.1016/j.tvjl.2025.106393","DOIUrl":null,"url":null,"abstract":"<div><div>Flagellin activates immune response through Toll-like Receptor 5 (TLR5) and can serve as a vaccine adjuvant. In this study, we evaluated the adjuvancy of the conserved domains of flagellins from three different bacteria: <em>Salmonella typhimurium</em>, <em>Bacillus subtilis</em>, and <em>Bacillus cereus</em>. The conserved domains were recombinantly expressed, and all three recombinant proteins demonstrated robust TLR5 activation <em>in vitro</em>. The recombinant proteins were formulated with inactivated porcine epidemic diarrhea virus (PEDV) as vaccines and mice were vaccinated for immune evaluation. Results showed that all three recombinant proteins enhanced proinflammatory response (IL-6 and TNF-α), cellular immunity, and PEDV-specific antibody response, when compared to the PEDV-alone group. In a virus neutralization test, all three recombinant proteins significantly enhanced the neutralization titer elicited by the PEDV vaccine. We conclude that despite differences in their sequences, conserved domains of flagellins from the three bacteria can activate TLR5 and may serve as vaccine adjuvants.</div></div>","PeriodicalId":23505,"journal":{"name":"Veterinary journal","volume":"313 ","pages":"Article 106393"},"PeriodicalIF":3.1000,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Conserved domains of flagellin as adjuvants for an inactivated vaccine against porcine epidemic diarrhea virus\",\"authors\":\"Haroon Afzal , Nguyen-Thanh Hoa , Asad Murtaza , Thu-Dung Doan , Yao-Chi Chung , Guan-Ming Ke , Li-Ting Cheng\",\"doi\":\"10.1016/j.tvjl.2025.106393\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Flagellin activates immune response through Toll-like Receptor 5 (TLR5) and can serve as a vaccine adjuvant. In this study, we evaluated the adjuvancy of the conserved domains of flagellins from three different bacteria: <em>Salmonella typhimurium</em>, <em>Bacillus subtilis</em>, and <em>Bacillus cereus</em>. The conserved domains were recombinantly expressed, and all three recombinant proteins demonstrated robust TLR5 activation <em>in vitro</em>. The recombinant proteins were formulated with inactivated porcine epidemic diarrhea virus (PEDV) as vaccines and mice were vaccinated for immune evaluation. Results showed that all three recombinant proteins enhanced proinflammatory response (IL-6 and TNF-α), cellular immunity, and PEDV-specific antibody response, when compared to the PEDV-alone group. In a virus neutralization test, all three recombinant proteins significantly enhanced the neutralization titer elicited by the PEDV vaccine. We conclude that despite differences in their sequences, conserved domains of flagellins from the three bacteria can activate TLR5 and may serve as vaccine adjuvants.</div></div>\",\"PeriodicalId\":23505,\"journal\":{\"name\":\"Veterinary journal\",\"volume\":\"313 \",\"pages\":\"Article 106393\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-06-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Veterinary journal\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1090023325000978\",\"RegionNum\":2,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"VETERINARY SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary journal","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1090023325000978","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
Conserved domains of flagellin as adjuvants for an inactivated vaccine against porcine epidemic diarrhea virus
Flagellin activates immune response through Toll-like Receptor 5 (TLR5) and can serve as a vaccine adjuvant. In this study, we evaluated the adjuvancy of the conserved domains of flagellins from three different bacteria: Salmonella typhimurium, Bacillus subtilis, and Bacillus cereus. The conserved domains were recombinantly expressed, and all three recombinant proteins demonstrated robust TLR5 activation in vitro. The recombinant proteins were formulated with inactivated porcine epidemic diarrhea virus (PEDV) as vaccines and mice were vaccinated for immune evaluation. Results showed that all three recombinant proteins enhanced proinflammatory response (IL-6 and TNF-α), cellular immunity, and PEDV-specific antibody response, when compared to the PEDV-alone group. In a virus neutralization test, all three recombinant proteins significantly enhanced the neutralization titer elicited by the PEDV vaccine. We conclude that despite differences in their sequences, conserved domains of flagellins from the three bacteria can activate TLR5 and may serve as vaccine adjuvants.
期刊介绍:
The Veterinary Journal (established 1875) publishes worldwide contributions on all aspects of veterinary science and its related subjects. It provides regular book reviews and a short communications section. The journal regularly commissions topical reviews and commentaries on features of major importance. Research areas include infectious diseases, applied biochemistry, parasitology, endocrinology, microbiology, immunology, pathology, pharmacology, physiology, molecular biology, immunogenetics, surgery, ophthalmology, dermatology and oncology.